ES2075272T5 - Composiciones dermatologicas conteniendo acido cis-urocanico. - Google Patents

Composiciones dermatologicas conteniendo acido cis-urocanico.

Info

Publication number
ES2075272T5
ES2075272T5 ES91110528T ES91110528T ES2075272T5 ES 2075272 T5 ES2075272 T5 ES 2075272T5 ES 91110528 T ES91110528 T ES 91110528T ES 91110528 T ES91110528 T ES 91110528T ES 2075272 T5 ES2075272 T5 ES 2075272T5
Authority
ES
Spain
Prior art keywords
dermatological compositions
urocanic acid
compositions containing
containing cis
cis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91110528T
Other languages
English (en)
Other versions
ES2075272T3 (es
Inventor
Franz Dr Stab
Gerhard Dr Sauermann
Udo Dr Hoppe
Walter Engel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandberg Development AB
Original Assignee
GS Development AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6409340&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2075272(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by GS Development AB filed Critical GS Development AB
Publication of ES2075272T3 publication Critical patent/ES2075272T3/es
Application granted granted Critical
Publication of ES2075272T5 publication Critical patent/ES2075272T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Birds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPOSICIONES DERMATOLOGICAS CON UN CONTENIDO DE ACIDOS DE UROZANIN DE CIS, ASI COMO EL EMPLEO DE COMPOSICIONES DERMATOLOGICAS CON UN CONTENIDO DE ACIDO DE UROZANIN PARA EL TRATAMIENTO Y LA PROFILAXIA DE DERMATOXIS ALERGICA O CONTAGIOSA, ASI COMO PARA EL CUIDADO DE LA RECUPERACION DE PIELES SENSIBLES.
ES91110528T 1990-06-29 1991-06-26 Composiciones dermatologicas conteniendo acido cis-urocanico. Expired - Lifetime ES2075272T5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4020739 1990-06-29

Publications (2)

Publication Number Publication Date
ES2075272T3 ES2075272T3 (es) 1995-10-01
ES2075272T5 true ES2075272T5 (es) 2002-07-01

Family

ID=6409340

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91110528T Expired - Lifetime ES2075272T5 (es) 1990-06-29 1991-06-26 Composiciones dermatologicas conteniendo acido cis-urocanico.

Country Status (5)

Country Link
EP (1) EP0467116B2 (es)
JP (1) JP3041365B2 (es)
AT (1) ATE126058T1 (es)
DE (2) DE59106201D1 (es)
ES (1) ES2075272T5 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4230076C2 (de) * 1992-09-09 1995-12-14 Beiersdorf Ag cis-Urocaninsäure als Antioxidans
CA2114968A1 (en) * 1993-02-25 1994-08-26 John Wille Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity
DE4307983A1 (de) * 1993-03-13 1994-09-15 Beiersdorf Ag Wirkstoffe und kosmetische und dermatologische Zubereitungen
GB9306473D0 (en) * 1993-03-29 1993-05-19 Bioglan Lab Ltd Pharmaceutically useful compounds
DE4429468C2 (de) 1994-08-19 1998-07-09 Beiersdorf Ag Verwendung hydrophobierter anroganischer Pigmente zum Erhalt der Urocaninsäurestatus der Haut beim Baden
WO1997047355A1 (en) * 1996-06-12 1997-12-18 Alza Corporation Reduction of skin sensitization in electrotransport drug delivery
FI20030379A0 (fi) * 2003-03-14 2003-03-14 Lasse Leino Uusi farmaseuttinen koostumus
FI20031793A0 (fi) * 2003-12-09 2003-12-09 Lasse Leino Uusi anti-proliferatiivinen farmaseuttinen koostumus
DE102004059546A1 (de) 2004-12-09 2006-06-22 Lucas Automotive Gmbh Elektronisches System zum Betreiben einer elektromechanischen Feststell-Bremsanlage
US20230135127A1 (en) * 2021-10-28 2023-05-04 Wei-ping Zeng Compositions and methods for disease treatment and prevention by ph modifiers and/or cell proliferation inhibitors

Also Published As

Publication number Publication date
EP0467116B2 (de) 2001-12-05
ES2075272T3 (es) 1995-10-01
DE4121030A1 (de) 1992-01-02
ATE126058T1 (de) 1995-08-15
DE59106201D1 (de) 1995-09-14
JP3041365B2 (ja) 2000-05-15
EP0467116B1 (de) 1995-08-09
EP0467116A1 (de) 1992-01-22
JPH04230321A (ja) 1992-08-19

Similar Documents

Publication Publication Date Title
NO1994018I1 (no) Mometasonfuroat
FI944549L (fi) Allergisten ja tulehdussairauksien hoidossa käyttökelpoiset yhdisteet
EP0590076A4 (en) Production of human hemoglobin in transgenic pigs
AU2118488A (en) Improvements in or relating to methods of treating damaged skin
MX9203653A (es) Composiciones amfotericas y formas polimericas de los alfa-hidroxiacidos.
ES2082875T3 (es) 3,5-di-terc-butil-4-hidroxifenilmetileno-derivados de tiazolidinonas, oxazolidinonas e imidazolidinonas 2-sustituidas utiles como agentes antiinflamatorios.
NO924474D0 (no) Orale preparater med forbedret tannhvittende effekt
NO933077L (no) Anvendelse av IL-4-reseptor for terapi i profylakse og diagnostikk av allergiske, virale og parasitiske og bakterielle sykdommer
DE69212620D1 (de) Verwendung von Glycosaminoglycanen zur Behandlung von diabetischer Nephropathie und diabetischer Neuropathie
DE69719931D1 (de) Verwendung von Acetylcystein zur Herstellung eines Arzneimittels zur Behandlung von chronischen Geschwüren
KR930702954A (ko) 조성물
FI915783A7 (fi) N-jodipropargyylioksikarbonyyliaminohappoesterit ja niiden johdannaiset sekä niiden käyttö antimikrobisina aineina
DK0631772T3 (da) Retinoidholdig sammensætning
ES2075272T5 (es) Composiciones dermatologicas conteniendo acido cis-urocanico.
FI931204A0 (fi) Nya, saosom lipooxigenasinhibitorer verkande aminobensosultamderivat
DK1063981T3 (da) Anvendelse af selegilin eller desmethylselegilin til behandling af sår, brandsår og dermatologiske skader
ATE521331T1 (de) Verwendung von bis-resorcinyltriazinderivaten in kosmetischen oder dermatologischen zubereitungen
DE68921209D1 (de) Zusammensetzungen und verfahren zur behandlung von hautkrankheiten und zur aktivierung der wundheilung.
DE59102350D1 (de) Lichtschutz.
DK0453603T3 (da) Piroxicamholdige farmaceutiske præparater til topisk anvendelse
DE58903964D1 (de) Fluessige orale formulierung.
FI911269A7 (fi) Menetelmä ja koostumus aktiivisten aineiden lisääntyneen pitoisuuden aikaansaamiseksi iholla iontoforeesin avulla
DE69210727D1 (de) Verwendung von 1,2-Dipalmitoyl-L-Alpha-Phosphatidyl-N,N-Dimethylethanilamine in dermatologischen und kosmetischen Zusammensetzungen
ATE117549T1 (de) Lysyl-oxidase-inhibitoren.
NO960545D0 (no) Behandling av skadelige virkninger i forbindelse med administrering av ekstracellulært hemoglobin

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 467116

Country of ref document: ES